PG insider Aguilar granted 780 RSUs in routine Form 4 filing

Form 4 highlights (filed 7 Aug 2025): Procter & Gamble’s Chief Research, Development & Innovation Officer, Moses V. J. Aguilar, disclosed routine equity accruals delivered through company compensation plans—no open-market trading occurred.

Rhea-AI Filing Summary

Form 4 highlights (filed 7 Aug 2025): Procter & Gamble’s Chief Research, Development & Innovation Officer, Moses V. J. Aguilar, disclosed routine equity accruals delivered through company compensation plans—no open-market trading occurred.

• New awards: 780 Restricted Stock Units (RSUs) granted on 08/07/2025; 12.5783 dividend-equivalent RSUs credited 05/15/2025; 0.6323 shares of Series A preferred stock credited 07/14/2025 via retirement plan.
• Cost: All issuances at $0, classified as code “A” (award) with “V” modifier, indicating non-discretionary, benefit-plan transactions.
• Post-transaction holdings: Direct ownership—25,351.0828 common shares plus 877.6365 RSUs; Indirect—6,750.7456 common shares and 1,782.2509 preferred shares held by plan trustees.
• RSUs and preferred shares convert to PG common stock upon retirement or plan distribution per plan rules.

No sales, dispositions, or market purchases were reported; the filing does not materially alter insider ownership percentage or signal a directional view on PG’s share price.

Insights

Securities Analyst

TL;DR — Routine plan-based awards; neutral for valuation.

The transactions are automatic grants tied to dividend reinvestment and retirement benefits, representing <0.001% of PG’s float. There is no cash outlay by the insider and no open-market activity, so they neither indicate bullish conviction nor raise governance concerns. Such filings are common for senior executives at large-cap issuers and carry de minimis market impact.

Insider Trade Summary

Grant/Award: 793.2106 shares

Grant/Award 6 txns

Insider Aguilar Moses Victor Javier

Role Chf Rsch, Dev & Innov Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	780	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
Grant/Award	Series A Preferred Stock	0.6323	$0.00	$0.00
Grant/Award	Restricted Stock Units	12.5783	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 877.6365 contracts (Direct); Series A Preferred Stock — 1,782.2509 contracts (Indirect, By Retirement Plan Trustee); Common Stock — 25,351.0828 shares (Direct); Common Stock — 6,750.7456 shares (Indirect, By Retirement Plan Trustee); Common Stock — 428.6033 shares (Indirect, International Stock Ownership Plan (Mexico) Trustee)

Footnotes (7)

1. F1. Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock and shares acquired through the issuer's dividend reinvestment plan.
2. F2. Reflects adjustment to PST through July 14, 2025.
3. F3. Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
4. F4. These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
5. F5. Higher of $6.82 (adjusted for 2-for-1 stock split effective May 21, 2004) or market price of Common Stock.
6. F6. Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price.
7. F7. Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025.

FAQ

What did PG insider Moses Aguilar report in the 7 Aug 2025 Form 4?

He received 780 RSUs, 12.5783 dividend-equivalent RSUs, and 0.6323 Series A preferred shares under company plans; no shares were sold.

How many Procter & Gamble shares does Aguilar now own?

After the awards he directly owns 25,351.0828 common shares and 877.6365 RSUs, plus indirect holdings via benefit plans.

Were any PG shares sold in this filing?

No. The Form 4 shows only acquisitions (code “A”); there were no dispositions or open-market sales.

What was the purchase price of the RSUs and preferred shares?

All awards were issued at $0 as part of compensation and dividend programs.

Do these transactions signal insider confidence in PG stock?

Because they are automatic, plan-based grants, they are generally viewed as neutral indicators rather than active insider buying.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/07/2025 - 03:19 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Aguilar Moses Victor Javier

(Last) (First) (Middle)

ONE PROCTER AND GAMBLE PLAZA

(Street)

CINCINNATI OH 45202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PROCTER & GAMBLE Co [ PG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chf Rsch, Dev & Innov Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								25,351.0828(1)	D
Common Stock								6,750.7456(2)	I	By Retirement Plan Trustee
Common Stock								428.6033	I	International Stock Ownership Plan (Mexico) Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)	05/15/2025		A	V	12.5783		(4)	(4)	Common Stock	12.5783	$0	97.6365	D
Series A Preferred Stock	(5)	07/14/2025		A	V	0.6323		(6)	(6)	Common Stock	0.6323	$0	1,782.2509	I	By Retirement Plan Trustee
Restricted Stock Units	(7)	08/07/2025		A		780		(4)	(4)	Common Stock	780	$0	780	D

Explanation of Responses:

1. Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock and shares acquired through the issuer's dividend reinvestment plan.

2. Reflects adjustment to PST through July 14, 2025.

3. Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.

4. These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

5. Higher of $6.82 (adjusted for 2-for-1 stock split effective May 21, 2004) or market price of Common Stock.

6. Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price.

7. Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025.

	/s/ Wednesday Shipp, attorney-in-fact for Mr. Aguilar Moses	08/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.